Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Par Drugs And Chemicals Limited
PAR | NSE
91.13
INR-1.64
-1.77%
PAR | NSE
Loading StockChartView...
About Par Drugs And Chemicals Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
91.13
Open
92.34
High
92.77
Low
91.04
Par Drugs and Chemicals Limited develops produces and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts dried aluminum hydroxide gel sodium aluminum silicate precipitated silica magnesium silicate colloidal silicon dioxide sucralfate USP and amorphous and blended products. The company also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara India.
View LessPAR | NSE
Risk
43.6
Sharpe
-0.34
Luna's Score
40/100
Recommendation
Sell
Luna says (PAR | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
What's not Working
Price Below SMA10D
Microcap (<300M USD)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
22.2%1 month
43.6%3 months
38.8%6 months
42.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
19.90
Fwd. PE
-
Price to book
3.51
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
11.51
Ent. to rev.
2.78
PEG
-
Other Fundamentals
EBITDA
228.98M
MarketCap
1.13B
MarketCap(USD)
11.86M
Div. yield
-
Op. margin
14.74
Erngs. growth
2.50
Rev. growth
-1.40
Ret. on equity
18.49
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
7.41
Range1M
17.50
Range3M
27.00
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.21
Price X volume
168.86K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 11.51 | 24.85 | Cheaper |
| Ent. to Revenue | 2.78 | 11.40 | Cheaper |
| PE Ratio | 19.90 | 51.36 | Cheaper |
| Price to Book | 3.51 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 38.82 | 42.17 | Par |
| Debt to Equity | - | 0.35 | - |
| Debt to Assets | - | 0.17 | - |
| Market Cap | 1.13B | 290.82B | Emerging |
